Randomized Clinical Trial Comparing Mitoxantrone with Epirubicin and with Doxorubicin, each Combined with Cyclophosphamide in the First-Line Treatment of Patients with Metastatic Breast Cancer
1990
Two hundred and twenty-four patients with advanced breast cancer were enrolled in a multicenter prospective randomized clinical study and received either doxorubicin (40 mg/m2), or epirubic
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
26
Citations
NaN
KQI